HCA Healthcare Research Institute (Sarah Cannon) — Nashville, Tennessee

HCA Healthcare Research Institute (Sarah Cannon) is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

HCA Healthcare Research Institute (Sarah Cannon) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer.

Sponsors: ABK Biomedical.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Healthcare Research Institute (Sarah Cannon)?

HCA Healthcare Research Institute (Sarah Cannon) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Healthcare Research Institute (Sarah Cannon) conducted?

HCA Healthcare Research Institute (Sarah Cannon) has 1 clinical trials on record, with 1 currently active. Their work covers Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer.

Is HCA Healthcare Research Institute (Sarah Cannon) accredited by Crixeo Clinical Trials?

HCA Healthcare Research Institute (Sarah Cannon) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Healthcare Research Institute (Sarah Cannon)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.